StonvexLoading…
StonvexStonvexStonvexCore line items from AMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.05B | $4.85B | $3.56B | $2.26B |
Operating Income | $-45.70M | $-17.40M | $-17.50M | $-53.30M |
Net Income | $-117.10M | $-632.40M | $-505.00M | $-4.70M |
EPS (Diluted) | $-0.22 | $-1.34 | $-1.10 | $-0.48 |
Total Assets | $7.68B | $8.02B | $8.02B | $8.17B |
Total Liabilities | $9.61B | $9.91B | $9.80B | $9.90B |
Cash & Equivalents | $339.20M | $428.50M | $365.80M | $423.70M |
Free Cash Flow OCF − CapEx | $-174.70M | $-365.90M | $-409.20M | $-328.10M |
Shares Outstanding | 539.66M | 472.90M | 459.38M | 432.06M |